LC/MS/MS analysis of leukotriene B4 and other eicosanoids in exhaled breath condensate for assessing lung inflammation.

Leukotriene (LT) B(4) is a potent inflammatory lipid mediator that has been involved in the pathophysiology of respiratory diseases including asthma. Exhaled breath condensate (EBC) is a non-invasive method to sample secretions from the airways. LC/MS/MS techniques for measuring LTB(4) concentrations in EBC have been developed and are suitable for an accurate quantitative assessment of its concentrations in EBC. LC/MS/MS for other eicosanoids including 8-isoprostane, a marker of oxidative stress, and cysteinyl-LTs have been developed. This article, mainly focused on LTB(4), presents the analytical aspects of the LC/MS/MS techniques for measuring LTB(4) and 8-isoprostane in EBC, provides examples of their application to the assessment of airway inflammation in patients with asthma and other respiratory diseases, and discusses their potential utility for non-invasive monitoring of drug therapy.

[1]  P. Montuschi,et al.  Isoprostanes: markers and mediators of oxidative stress , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  P. Montuschi,et al.  Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patients , 2004, Thorax.

[3]  P. Montuschi,et al.  Exhaled leukotrienes and prostaglandins in asthma. , 2002, The Journal of allergy and clinical immunology.

[4]  P. Montuschi.  New Perspectives in Monitoring Lung Inflammation : Analysis of Exhaled Breath Condensate , 2004 .

[5]  S. Dahlén,et al.  Pharmacological modulation of the leukotriene pathway in allergic airway disease. , 2007, Drug discovery today.

[6]  D. Pelclova,et al.  Increased 8-isoprostane, a marker of oxidative stress in exhaled breath condensate in subjects with asbestos exposure. , 2008, Industrial health.

[7]  R. Stockley,et al.  The interrelationship of sputum inflammatory markers in patients with chronic bronchitis. , 1999, American journal of respiratory and critical care medicine.

[8]  P. Montuschi,et al.  Ion trap liquid chromatography/tandem mass spectrometry analysis of leukotriene B4 in exhaled breath condensate. , 2004, Rapid communications in mass spectrometry : RCM.

[9]  P. Montuschi,et al.  Insights into oxidative stress: the isoprostanes. , 2007, Current medicinal chemistry.

[10]  A. Wardlaw,et al.  Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases. , 1989, The Journal of allergy and clinical immunology.

[11]  P. Montuschi,et al.  Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma. , 2006, The Journal of allergy and clinical immunology.

[12]  J. S. Seggev,et al.  Serum leukotriene B4 levels in patients with obstructive pulmonary disease. , 1991, Chest.

[13]  P. Montuschi,et al.  CT-guided pleural biopsy preferable to traditional Abram’s needle in diagnosing malignant pleural disease , 2003, Thorax.

[14]  P. Montuschi,et al.  Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic children. , 2004, The Journal of allergy and clinical immunology.

[15]  G. Corbo,et al.  Validation of leukotriene B4 measurements in exhaled breath condensate , 2003, Inflammation Research.

[16]  B. Christman,et al.  Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. , 1998, Chest.